Oncomed Pharmaceuticals, Inc.
Records under this name other than patents Oncomed Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Oncomed Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,723,477 | Compositions and Methods for Inhibiting Wnt-Dependent Solid Tumor Cell Growth Formerly held In force · High confidence | In force | High confidence | |
| US 8,206,713 | Method of Treating Cancer Using Antibodies to a Non-Ligand Binding Region of NOTCH2 Formerly held In force · High confidence | In force | High confidence | |
| US 8,404,237 | Antibodies to the NOTCH1 Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 9,676,865 | Antibodies to a Non-Ligand Binding Region of at Least Two Notch Receptors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,228,020 | Compositions and Methods for Diagnosing and Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,919,092 | Antibodies to Notch Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 7,750,124 | Anti-Human DLL4 Antibodies and Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,376,497 | Compositions and Methods for Diagnosing and Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,158,758 | Compositions and Methods for Treating and Diagnosing Cancer Formerly held In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 8,540,989 | Compositions and Methods for Treating and Diagnosing Cancer Formerly held In force · High confidence | In force | High confidence |